{"podcast":{"title":"Business News Today | 2 Min News | The Daily News Now!","slug":"business-finance-news-today-2-min-news-the-daily-news-now-7726192","podcast_index_feed_id":7726192,"rss_url":"https://feeds.fastcast.ai/the-daily-news-now-business.xml","website_url":"https://thednn.ai/","image_url":"https://image.fastcast.ai/cover/a77b5c94-431e-4490-8653-1f676f1da586.png","author":"The Daily News Now!","episode_count":1320,"summary":"Hosted by Corey with the Story. Stay informed with the latest business, stock market, and finance headlines, updates, and breaking stories delivered daily in quick, engaging episodes. Subscribe! The Daily News Now! — Every city. Every story. AI-powered. Advertise on DNN: advertise@thednn.ai","last_synced_at":"2026-06-17T18:18:57.837082+00:00","page_url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192"},"episode":{"title":"Bristol Myers Squibb's Value Trap","slug":"bristol-myers-squibb-s-value-trap","published_at":"2026-06-02T04:02:28+00:00","page_url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/bristol-myers-squibb-s-value-trap","show_page_url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192","url":"https://api.fastcast.ai/audio/145b272f-12b7-425d-8d9b-322f0820fa13.mp3","audio_url":"https://api.fastcast.ai/audio/145b272f-12b7-425d-8d9b-322f0820fa13.mp3","summary":"Bristol Myers Squibb looks like a bargain on paper with a low P/E and a juicy dividend, but looming patent expirations on key drugs could hurt profits. While the company has a proven track record and long-term potential, short-term revenue risks make it a risky play for quick gains. Best suited for patient investors willing to hold through the next decade. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/52909f8f2a0c4683","meta_description":"Bristol Myers Squibb looks like a bargain on paper with a low P/E and a juicy dividend, but looming patent expirations on key drugs could hurt profits. Wh…","key_points":[],"chapters":[],"topics":[],"duration_seconds":108,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/business-finance-news-today-2-min-news-the-daily-news-now-7726192/episodes/bristol-myers-squibb-s-value-trap/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/bristol-myers-squibb-s-value-trap.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}